Polymorphisms of Prostate-Specific Antigen Gene Promoter: Determination From Cord Blood Collected on Filter Paper

Annals of Clinical and Laboratory Science

Volumn 33, Issue 4, 2003, Pages 429-434

  Liu, Jie ^a   Zhang, Jin San ^b   Young, Charles Y F ^b   Kao, Pai C ^b  

^a Guangdong H S C Ther Tech Ctr   (China)

^b MAYO CLINIC   (United States)

Author keywords

Androgen response element 1; Chinese subjects; Cord blood; Prostate cancer; PSA gene promoter

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AMINO ACID SUBSTITUTION; ANDROGEN RESPONSE ELEMENT 1; ARTICLE; BLOOD BANK; BLOOD SAMPLING; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ETHNOLOGY; FEMALE; FILTER; GENETIC POLYMORPHISM; GENETIC TRAIT; HUMAN; MALE; MARKER GENE; NEWBORN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD;

ADENINE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD SPECIMEN COLLECTION; FEMALE; FETAL BLOOD; GENE FREQUENCY; HUMANS; INFANT, NEWBORN; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN;

EID: 0142025359     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S, Swallen K, Guillermo T, Suh D, Alvarez-Martinez L, Ward F. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 1999;10:525-537.
3. Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control 1995;6:492-498.
4. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999; 161:152-155.
5. Farkas A, Marcella S, Rhoads GG. Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis 2000;10:69-75.
6. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60-67.
7. Shibata A, Whittemore AS. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 1997;32:65-72.
8. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-1592.
9. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354-360.
10. Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma J, Mann J, McPherson K. Mortality in vegetarians and non vegetarians. A collaborative analysis of 8,300 deaths among 76,000 men and women in five prospective studies. Public Helath Nutr 1998;1:33-41.
11. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002;360:861-868.
12. Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Carvalho R, Lopes C. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and cirulcating tumor cells. Prostate 2002;53:88-94.
13. Xue WM, Coetzee GA, Ross RK, Irvine R, Kolonel L, Henderson BE, Ingles SA. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2001;10:575-579.
14. Wu TJ, Yu HE, Song L, Taylor RL, Kao PC. Filter paper collection of plasma for IGF-I test in patients with acromegaly. Ann Clin Lab Sci 2002;32:287-291.
15. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000;60:839-841.
16. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 2000;60:5111-5116.
17. Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2001;10:1077-1082.
18. Mononen N, Ikonen T, Autio V, Rokman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet 2002;111:166-171.
19. Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Tamaki T, Mori I, Sakurai T, Kakudo K. Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. Anticancer Res 2002;22:1825-1828.
20. Sauter ER, Chervoneva I, Diamandis A, Khosravi JM, Litwin S, Diamandis EP. Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer. Cancer Detect Prev 2002;26:149-157.
21. Dunn JE. Cancer epidemiology in populations of the United States, with emphasis on Hawaii and California, and Japan. Cancer Res 1975;35:3240-3245.
22. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein, and their beta-glycoside conjugates. Antitumor isoflavones in soybean foods from American and Asian diets. J Agri Food Chem 1993;41:1961-1967.
23. Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S. Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochem Pharmacol 2002;63:1165-1176.
24. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997;387:561.
25. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993;85:1038-1049.